NZ219516A - Fusion proteins of hbcag (hepatitis b virus core antigen) - Google Patents
Fusion proteins of hbcag (hepatitis b virus core antigen)Info
- Publication number
- NZ219516A NZ219516A NZ219516A NZ21951687A NZ219516A NZ 219516 A NZ219516 A NZ 219516A NZ 219516 A NZ219516 A NZ 219516A NZ 21951687 A NZ21951687 A NZ 21951687A NZ 219516 A NZ219516 A NZ 219516A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hbcag
- hepatitis
- fusion proteins
- core antigen
- virus core
- Prior art date
Links
- 101710132601 Capsid protein Proteins 0.000 title 1
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1294887A | 1987-02-10 | 1987-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ219516A true NZ219516A (en) | 1991-02-26 |
Family
ID=21757520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ219516A NZ219516A (en) | 1987-02-10 | 1987-03-05 | Fusion proteins of hbcag (hepatitis b virus core antigen) |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS63196299A (en) |
AU (2) | AU596154B2 (en) |
CA (1) | CA1319628C (en) |
NZ (1) | NZ219516A (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ235315A (en) * | 1989-09-19 | 1991-09-25 | Wellcome Found | Chimaeric hepadnavirus core antigen proteins and their construction |
SE468050C (en) * | 1991-03-15 | 1998-04-27 | Pharmacia & Upjohn Ab | Recombinant human factor VIII derivative |
ATE228564T1 (en) * | 1991-09-13 | 2002-12-15 | Chiron Corp | COMPOSITION OF MULTIPLE IMMUNOREACTIVE HEPATITIS C VIRUS POLYPEPTIDES |
AU745951B2 (en) * | 1997-08-05 | 2002-04-11 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | New immunoprotective influenza antigen and its use in vaccination |
US7731972B1 (en) | 2000-02-04 | 2010-06-08 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Immunoprotective influenza antigen and its use in vaccination |
US8420102B2 (en) | 2006-03-07 | 2013-04-16 | Vaxinnate Corporation | Compositions that include hemagglutinin |
AR052195A1 (en) | 2005-01-19 | 2007-03-07 | Vaxinnate Corp | COMPOSITIONS OF MOLECULAR PATTERNS ASSOCIATED WITH PATHOGENS IN METHODS OF USE |
CA2721246A1 (en) | 2008-04-18 | 2009-10-22 | Vaxinnate Corporation | Deletion mutants of flagellin and methods of use |
ES2616533T3 (en) * | 2008-12-25 | 2017-06-13 | The Chemo-Sero-Therapeutic Research Institute | Recombinant vaccine for avian infectious rhinitis and process to produce it |
US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
EP3342866B1 (en) * | 2015-08-25 | 2021-12-15 | Xiamen University | Polypeptide carrier for presenting target polypeptide and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW18282A1 (en) * | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
IE56716B1 (en) * | 1983-01-19 | 1991-11-20 | Genentech Inc | Method for producing human tpa and expression vectors therefor |
EP0175261B1 (en) * | 1984-09-12 | 1991-12-11 | Chiron Corporation | Hybrid particle immunogens |
JPS6274295A (en) * | 1985-09-25 | 1987-04-06 | チロン コ−ポレイシヨン | Hybrid granular immunogen |
NZ219515A (en) * | 1987-02-10 | 1989-09-27 | Wellcome Found | Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope |
-
1987
- 1987-03-05 NZ NZ219516A patent/NZ219516A/en unknown
- 1987-03-06 AU AU69792/87A patent/AU596154B2/en not_active Ceased
- 1987-03-07 JP JP62052829A patent/JPS63196299A/en active Pending
- 1987-04-08 CA CA000534146A patent/CA1319628C/en not_active Expired - Fee Related
-
1990
- 1990-02-08 AU AU49273/90A patent/AU642859B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU6979287A (en) | 1988-08-11 |
AU4927390A (en) | 1990-08-09 |
AU596154B2 (en) | 1990-04-26 |
JPS63196299A (en) | 1988-08-15 |
AU642859B2 (en) | 1993-11-04 |
CA1319628C (en) | 1993-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86640A (en) | HEPATITIS B VIRUS SURFACE ANTIGENS AND HYBRID ANTIGENS CONTAINING THEM | |
HK38293A (en) | Hepatitis c virus | |
DK643387D0 (en) | T-CELL EPITOPES OF HEPATITIS B VIRUS NUCLEOCAPSIDE PROTEIN | |
GB2212511B (en) | Hepatitis c virus | |
PH25249A (en) | Method for producing hepatitis b virus proteins in yeast | |
NZ219516A (en) | Fusion proteins of hbcag (hepatitis b virus core antigen) | |
PT85137A (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen | |
AU5223990A (en) | Monoclonal antibodies to Pres2 and Pres1 polypeptides of the hepatitis B viral envelope | |
IL90408A0 (en) | Method for producing non-hyperglycosylated hepatitis b virus proteins | |
DK610587D0 (en) | METHOD AND METHOD OF ANY ANTIBODY FOR HEPATITIS B CORE ANTIGEN | |
IL85811A0 (en) | Assay for detecting hepatitis antigens and aids antibodies | |
AU7648191A (en) | Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope | |
EP0503950A3 (en) | Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells | |
AU1216988A (en) | Immunogenic fusion proteins which contain Epstein-Barr virus protein | |
AU1668788A (en) | Method of vaccination for hepatitis b virus | |
GB2181434A (en) | Hepatitis b virus vaccine and process for its preparation | |
GB8622883D0 (en) | Expression of hepatitis b viral antigens | |
EP0503252A3 (en) | Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines | |
IE891804L (en) | Nonhyperglycosylated hepatitis b virus proteins | |
IE891315L (en) | Expression of hepatitis b. pres2 protein in methylotrophic¹yeasts | |
GB8621578D0 (en) | Hepatitis b viral antigens | |
CS627787A1 (en) | Mouse lymphocytar hybridome producing antibodies against antigen of b-hepatitis virus (hbeag) | |
IE852110L (en) | Recombinant hepatitis antigen | |
JPS645492A (en) | Production of b type hepatitis virus protein in yeast | |
NZ215820A (en) | Hepatitis b antigen formed by recombinant dna techniques |